BIO-RAD LABORATORIES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.20B | $10.20B | $802.3M |
| Jun 2022 | $1.20B | $8.95B | $596.6M |
| Sep 2022 | $1.20B | $8.48B | $517.9M |
| Dec 2022 | $1.20B | $9.62B | $434.2M |
| Mar 2023 | $1.20B | $9.76B | $464.1M |
| Jun 2023 | $1.20B | $8.45B | $390.0M |
| Sep 2023 | $1.20B | $8.42B | $457.9M |
| Dec 2023 | $1.20B | $8.74B | $403.8M |
| Mar 2024 | $1.20B | $9.05B | $433.3M |
| Jun 2024 | $1.20B | $6.78B | $406.9M |
| Sep 2024 | $1.20B | $7.49B | $410.4M |
| Dec 2024 | $1.20B | $6.57B | $488.1M |
| Mar 2025 | $1.20B | $6.68B | $521.4M |
| Jun 2025 | $1.20B | $7.13B | $369.3M |
| Sep 2025 | $1.20B | $6.74B | $395.8M |
| Dec 2025 | $1.20B | $7.45B | $529.8M |
| Mar 2026 | $802.9M | $6.85B | $507.2M |
| Jun 2026 | $803.0M | $7.17B | $517.0M |